Search
Search Results
##search.searchResults.foundPlural##
-
THROMBOCYTOPENIA IN PATIENTS WITH CHRONIC HEPATITIS C VIRUS INFECTION
4147PDF: 1965HTML: 1772 -
SPHINGOMONAS PAUCIMOBILIS INFECTIONS IN CHILDREN: NOSOCOMIAL VERSUS COMMUNITY ACQUIRED INFECTIONS
1796PDF: 1022HTML: 2042cover: 183Table 1. Co-morbidities associated with Sphingomonas paucimobilis infections.: 182Figure 1. The antimicrobial susceptibility patterns of Sphingomonas paucimobilis isolated from clinical specimens: 1588title page: 193 -
Acquired Sideroblastic Anemia: An exploratory Comparative Statistical Analysis Between Clonal and Non-clonal cases Acquired Sideroblastic Anemia
976PDF: 595HTML: 353 -
THERAPY-RELATED MYELOID NEOPLASM IN NON-HODGKIN LYMPHOMA SURVIVORS
2599PDF: 751HTML: 2307 -
CD48 AS A NOVEL EARLY BIOMARKER COMPLEMENTING PROCALCITONIN AND LACTATE FOR PREDICTING BACTEREMIA IN PEDIATRIC FEBRILE NEUTROPENIA: A PROSPECTIVE COHORT STUDY CD48 A NOVEL EARLY BIOMARKER PREDICTING BACTERIEMIA
898PDF: 664HTML: 112 -
RARE CYTOGENETIC ABNORMALITIES IN MYELODYSPLASTIC SYNDROMES
3801PDF: 1671HTML: 11612Figures Haase: 203 -
TUBERCULOSIS IN HEMATOPOIETIC STEM CELL TRANSPLANT PATIENTS.
2650PDF: 953HTML: 3645 -
Delivery in asymptomatic Italian woman with SARS-CoV-2 infection. Delivery in asymptomatic woman with SARS-CoV-2 infection
1908PDF: 988HTML: 228 -
PROGNOSTIC FACTORS IN HODGKIN LYMPHOMA
3349PDF: 1973HTML: 7476 -
A CRITICAL HISTORY OF CHRONIC MYELOID LEUKEMIA
3260PDF: 1341HTML: 4143 -
IMPACT OF QUALITATIVE AND QUANTITATIVE IMMUNOPARESIS ON EARLY INFECTION RISK IN PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA Immunoparesis and early infection risk in myeloma
42PDF: 37HTML: 2 -
WHAT ARE FUNGAL INFECTIONS?
4222PDF: 2399HTML: 27626de Pauw: 240 -
A MULTICENTER ICET-A SURVEY ON ADHERENCE TO ANNUAL ORAL GLUCOSE TOLERANCE TEST (OGTT) SCREENING IN TRANSFUSION-DEPENDENT THALASSEMIA (TDT) PATIENTS - THE EXPERT CLINICIANS’ OPINION ON FACTORS INFLUENCING THE ADHERENCE AND ON ALTERNATIVE STRATEGIES FOR ADHERENCE OPTIMIZATION Survey on adherence to annual OGTT in thalassemia
2931PDF: 1347HTML: 159 -
QUALITY OF LIFE ASSESSMENT IN MULTIPLE MYELOMA PATIENTS UNDERGOING DOSE-REDUCED TANDEM AUTOLOGOUS STEM CELL TRANSPLANTATION
1411PDF: 686HTML: 1379cover letter: 210 -
HEMATOPOIETIC CELL TRANSPLANTATION FOR OLDER PATIENTS WITH MDS
2036PDF: 766HTML: 3117 -
FROM LEGACY TO INNOVATION: PIDOTIMOD’S EXPANDING THERAPEUTIC HORIZON Pidotimod: Revisiting a Classic Immunomodulator
2573PDF: 950HTML: 565 -
LETERMOVIR PRIMARY CYTOMEGALOVIRUS PROPHYLAXIS IN ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANT RECIPIENTS: COULD INFECTION AND DISEASE NO LONGER BE A SIGNIFICANT PROBLEM? Letermovir and Cytomegalovirus Prophylaxis in HSCT
1317PDF: 1021HTML: 125 -
NURSING MANAGEMENT OF HAEMORRHAGIC CYSTITIS IN PATIENTS UNDERGOING HAEMATOPOIETIC STEM CELL TRANSPLANTATION: A MULTICENTRE ITALIAN SURVEY Nursing management of haemorrhagic cystitis
1895PDF: 1061HTML: 291 -
END-OF-LIFE CARE IN SICKLE CELL DISEASE AND TRASFUSION DEPENDEND-β-THALASSEMIA: CLINICAL, PSYCHOLOGICAL, AND ETHICAL CONSIDERATION Challenges in Supportive Care, Equity, and Compassion at End of Life
1041PDF: 712Html: 161 -
NURSES’ PHYSICAL AND PSYCHOLOGICAL SYMPTOMS DURING THE FIRST COVID-19 LOCKDOWN IN ITALY A nationwide cross-sectional study in stem cell transplantation setting.
1926PDF: 827HTML: 229 -
PROPHYLAXIS OF MALARIA
3034PDF: 1041HTML: 17834Figures SChwartz: 168 -
Postpandemic influenza A/H1N1pdm09 is still causing severe perinatal complications
1363PDF: 989HTML: 2008Cover letter: 201







